Cargando…

Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report

Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It w...

Descripción completa

Detalles Bibliográficos
Autores principales: Abulaila, Karim J., Sabha, Mosa A., Misk, Momin R., Alhalabeye, Amr A., Jobran, Afnan W.M., Abunejma, Fawzy M., Bakri, Izzeddin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205224/
https://www.ncbi.nlm.nih.gov/pubmed/37229047
http://dx.doi.org/10.1097/MS9.0000000000000476
_version_ 1785045990158368768
author Abulaila, Karim J.
Sabha, Mosa A.
Misk, Momin R.
Alhalabeye, Amr A.
Jobran, Afnan W.M.
Abunejma, Fawzy M.
Bakri, Izzeddin A.
author_facet Abulaila, Karim J.
Sabha, Mosa A.
Misk, Momin R.
Alhalabeye, Amr A.
Jobran, Afnan W.M.
Abunejma, Fawzy M.
Bakri, Izzeddin A.
author_sort Abulaila, Karim J.
collection PubMed
description Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It was first identified by Japanese pathologists Kikuchi and Fujimoto. KFD damages the meninges, the brain parenchyma, and peripheral nerves in addition to the CNS. Neurological symptoms may even be the most obvious clinical manifestations or initial symptoms of the disease. CASE PRESENTATION: We present a unique case of a 7-year-old male patient who was diagnosed with activated phosphoinositide 3-kinase delta syndrome 2 (APDS 2) associated with KFD, a HNL during a workup for fever without a focus and cervical lymphadenopathy. CONCLUSION: Highlighted the unique relationship between two uncommon conditions and stressed the significance of adding KFD to the list of possible diagnoses for lymphadenopathy in APDS 2. Furthermore, we demonstrate that patients with APDS 2 may exhibit low immunoglobulin M levels.
format Online
Article
Text
id pubmed-10205224
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102052242023-05-24 Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report Abulaila, Karim J. Sabha, Mosa A. Misk, Momin R. Alhalabeye, Amr A. Jobran, Afnan W.M. Abunejma, Fawzy M. Bakri, Izzeddin A. Ann Med Surg (Lond) Case Reports Histiocytic necrotic lymphadenitis (HNL), also known as Kikuchi–Fujimoto disease (KFD), is a rare local lymphadenopathy with a benign course and clinical manifestations such as fever, lymphadenopathy, rash, hepatosplenomegaly, central nervous system (CNS) symptoms, and hemophilic cell syndrome. It was first identified by Japanese pathologists Kikuchi and Fujimoto. KFD damages the meninges, the brain parenchyma, and peripheral nerves in addition to the CNS. Neurological symptoms may even be the most obvious clinical manifestations or initial symptoms of the disease. CASE PRESENTATION: We present a unique case of a 7-year-old male patient who was diagnosed with activated phosphoinositide 3-kinase delta syndrome 2 (APDS 2) associated with KFD, a HNL during a workup for fever without a focus and cervical lymphadenopathy. CONCLUSION: Highlighted the unique relationship between two uncommon conditions and stressed the significance of adding KFD to the list of possible diagnoses for lymphadenopathy in APDS 2. Furthermore, we demonstrate that patients with APDS 2 may exhibit low immunoglobulin M levels. Lippincott Williams & Wilkins 2023-04-07 /pmc/articles/PMC10205224/ /pubmed/37229047 http://dx.doi.org/10.1097/MS9.0000000000000476 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (https://creativecommons.org/licenses/by-nc/4.0/) (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case Reports
Abulaila, Karim J.
Sabha, Mosa A.
Misk, Momin R.
Alhalabeye, Amr A.
Jobran, Afnan W.M.
Abunejma, Fawzy M.
Bakri, Izzeddin A.
Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title_full Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title_fullStr Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title_full_unstemmed Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title_short Activated phosphoinositide 3-kinase delta syndrome 2 associated with Kikuchi–Fujimoto disease: a rare Palestinian case report
title_sort activated phosphoinositide 3-kinase delta syndrome 2 associated with kikuchi–fujimoto disease: a rare palestinian case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205224/
https://www.ncbi.nlm.nih.gov/pubmed/37229047
http://dx.doi.org/10.1097/MS9.0000000000000476
work_keys_str_mv AT abulailakarimj activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT sabhamosaa activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT miskmominr activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT alhalabeyeamra activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT jobranafnanwm activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT abunejmafawzym activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport
AT bakriizzeddina activatedphosphoinositide3kinasedeltasyndrome2associatedwithkikuchifujimotodiseaseararepalestiniancasereport